No Picture
News

Mark Mallon charts post-Ironwood course by taking CEO job at NeoGenomics; GlaxoSmithKline vet Feng Ren joins Insilico as CSO

Mark Mallon
→ Mark Mallon steps aside at Ironwood on March 12 after close to two years at the helm, and he already has a new change of scenery squared away. Beginning April 19, Mallon takes charge as CEO of cancer-focused genetic test maker NeoGenomics… […]

No Picture
News

Octave Bioscience to Present New Analyses Addressing the Complex Unmet Needs of Multiple Sclerosis Through Quantitative and Image-Based Measurement of Multiple Pathways and Their Biomarkers at the ACTRIMS Forum 2021

MENLO PARK, Calif.–(BUSINESS WIRE)–Octave Bioscience (Octave), the developer of a fully integrated care management platform for multiple sclerosis (MS) and other neurodegenerative diseases, today announced the presentation of five posters at the ACTR… […]

No Picture
News

Atreca Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Corporate Developments

SOUTH SAN FRANCISCO, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) — Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation … […]

No Picture
News

Vaxart Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results

SOUTH SAN FRANCISCO, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) — Vaxart, Inc. (Nasdaq: VXRT) a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced that it p… […]

No Picture
News

Denali Therapeutics Reports Full Year 2020 Financial Results and Business Highlights

SOUTH SAN FRANCISCO, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) — Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain barrier (BBB) for neurodegenera… […]

No Picture
News

Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results

SAN FRANCISCO, Feb. 25, 2021 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR) today provided a corporate update and reported financial results for the fourth quarter and full year ended December 31, 2020. […]

No Picture
News

Big biotech, UCs launch $53M effort targeting Alzheimer’s, other brain diseases

UCSF and UC Berkeley will receive $53 million over 10 years as part of a collaboration with biotech giant Genentech Inc. and its Swiss parent Roche to research potential new treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, ALS, autism… […]

No Picture
News

Big biotech, UCs launch $53M effort targeting Alzheimer’s, other brain diseases

UCSF and UC Berkeley will receive $53 million over 10 years as part of a collaboration with biotech giant Genentech Inc. and its Swiss parent Roche to research potential new treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, ALS, autism… […]

No Picture
News

Argonne National Laboratory Computer Models Help PG&E Plan for Climate Change Impacts, Including Wildfires

LEMONT, Ill. & SAN FRANCISCO–(BUSINESS WIRE)–Scientists at Argonne are helping a major U.S. utility company protect its current infrastructure and better plan for the future in a changing climate […]